Monday, October 29, 2007

Using marker pens on patients: a potential source of cross infection with MRSA.

Using marker pens on patients: a potential source of cross infection with MRSA.
Ann R Coll Surg Engl. 2007 Oct

Tadiparthi S, Shokrollahi K, Juma A, Croall J.
Department of Plastic and Reconstructive Surgery, Countess of Chester Hospital, Chester, UK.
tadiparthi@hotmail.co.uk

Keywords: MARKER PENS; MRSA; SURGICAL MARKING; CORRECT SITE SURGERY; NOSOCOMIAL INFECTION; PRE-OPERATIVE MARKING

INTRODUCTION: Marker pens are widely used in surgery but pre-operative marking of patients may be a cause of bacterial cross-infection.

PATIENTS AND METHODS: Two experiments were performed to assess whether marking pens can be cause of cross-infection: (i) 26 indelible marker pens were collected from surgical wards for analysis; and (ii) 'fresh' as well as 'dry' (artificially dried by removing cap and exposing tip for 2 h) new permanent marker pens, and whiteboard marker pens were inoculated by dipping the tips into various concentrations of methicillin-resistant Staphylococcus aureus (MRSA). Each pen was inoculated onto 2 blood agar plates at 0 (immediately after inoculation) to 30 min at various intervals, 4 h and 24 h. The plates were incubated for 18 h at 35 degrees C in an incubator.

RESULTS: Of 26 pens collected from the wards, 2 cultured Micrococci spp. (skin commensals). The constituents of new 'fresh' pen tips rapidly kill MRSA - in all cases by 4 h, but usually within minutes. At high inoculum concentrations, MRSA is not killed immediately. Dry marker pens harbour MRSA for at least 30 min and probably longer.

CONCLUSIONS: Marker pens can act as fomites for nosocomial infection. The ethanol-based ink in permanent marker pens has a bactericidal action against MRSA that starts within seconds, and they are likely to be safe to use with a gap of at least 2 min between patients. Usually, harmless skin commensals are not pathogenic except in immunocompromised patients. Old or dried-out marker pens can harbour pathogens and should be discarded before attempted use on patients. We recommend disposable markers for the immunocompromised and patients with a known positive MRSA status.

Ingenta